Given the vast number of cargoes which rely on XPO1 for nuclear transport it is reasonable to suspect that selinexor response may be governed by the cellular context of signaling mechanisms downstream of nuclear export inhibition and the differential dependence of tumor cell survival on these downstream mechanisms in one type of cancer versus another. The gene discussed is XPO1; the disease is neoplasm.